• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMET FRANCE S.A.R.L. REFOBACIN BONE CEMENT R 1X40G; BONE CEMENT, ANTIBIOTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMET FRANCE S.A.R.L. REFOBACIN BONE CEMENT R 1X40G; BONE CEMENT, ANTIBIOTIC Back to Search Results
Model Number N/A
Device Problem Unsealed Device Packaging (1444)
Patient Problems No Consequences Or Impact To Patient (2199); No Patient Involvement (2645)
Event Date 10/17/2018
Event Type  malfunction  
Manufacturer Narrative
(b)(4).Report source, foreign - event occurred in (b)(6).The investigation is in process.Once the investigation has been completed, a follow-up mdr will be submitted.
 
Event Description
It was reported that before surgery the outer packaging of bone cement was complete, but there was leakage of powder and the inner sterile packaging was opened.
 
Event Description
It has been reported that before surgery the outer packaging of bone cement was complete, but there was leakage of powder and the inner sterile packaging was opened.
 
Manufacturer Narrative
(b)(4).This follow-up report is being submitted to relay additional information.The following section has been updated : device identification, initial reporter name and address, initial reporter health professional, mfr site, report source, date received by mfr, follow up type, device evaluated by mfr, evaluation codes, remedial action initiated, additional narrative.Remedial action initiated- corrective action has been initiated for the reported issue.The device will not be returned to the manufacturer.Therefore it will not be analyzed.The device manufacturing quality record indicates that the released product met all requirements to perform as intended.Investigation showed that the most probable root cause was related to manufacturing.Corrective action has been initiated to address reported issue.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
REFOBACIN BONE CEMENT R 1X40G
Type of Device
BONE CEMENT, ANTIBIOTIC
Manufacturer (Section D)
BIOMET FRANCE S.A.R.L.
plateau de lautagne bp75
valence cedex 26903
FR  26903
MDR Report Key8240376
MDR Text Key132926383
Report Number3006946279-2018-00412
Device Sequence Number1
Product Code MBB
Combination Product (y/n)N
PMA/PMN Number
K150850
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign
Remedial Action Modification/Adjustment
Type of Report Initial,Followup
Report Date 05/24/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/31/2020
Device Model NumberN/A
Device Catalogue Number3003940001
Device Lot NumberA746BA1504
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 10/22/2018
Initial Date FDA Received01/11/2019
Supplement Dates Manufacturer Received05/23/2019
Supplement Dates FDA Received05/24/2019
Is This a Reprocessed and Reused Single-Use Device? No
Removal/Correction NumberN/A
Patient Sequence Number1
-
-